CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment.
Saved in:
| Title: | CDK4/6 inhibitors in breast cancer therapy: mechanisms of drug resistance and strategies for treatment. |
|---|---|
| Authors: | Gao T; Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China., Sun Y; Department of Health Management Center, The Affiliated Hospital of Qingdao University, Qingdao, China., Leng P; Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China., Liu D; Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China., Guo Q; Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China., Li J; Department of Pharmacy, The Affiliated Hospital of Qingdao University, Qingdao, China. |
| Source: | Frontiers in pharmacology [Front Pharmacol] 2025 May 12; Vol. 16, pp. 1549520. Date of Electronic Publication: 2025 May 12 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Frontiers Media] Country of Publication: Switzerland NLM ID: 101548923 Publication Model: eCollection Cited Medium: Print ISSN: 1663-9812 (Print) Linking ISSN: 16639812 NLM ISO Abbreviation: Front Pharmacol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
